Crossmark

Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study

Crossref DOI link: https://doi.org/10.1007/s00259-022-06047-6

Published Online: 2022-11-22

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ke, Zhi-Bin

Chen, Shao-Ming

Chen, Jia-Yin

Chen, Shao-Hao

You, Qi

Sun, Jiang-Bo

Xue, Yu-Ting

Sun, Xiong-Lin

Wu, Xiao-Hui

Zheng, Qing-Shui

Wei, Yong

Xue, Xue-Yi

Xu, Ning https://orcid.org/0000-0001-7909-7025
License Information

Text and Data Mining valid from 2022-11-22

Version of Record valid from 2022-11-22
More Information

Article History

Received: 18 August 2022

Accepted: 13 November 2022

First Online: 22 November 2022

Declarations

:

: This study was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (Approved No. of ethic committee: MRCTA, ECFAH of FMU [2021]208), and all patients provided written informed consent.

: All authors read the final manuscript and agreed to publish this manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below